{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:33:10Z","timestamp":1792873990237,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,19]],"date-time":"2016-06-19T00:00:00Z","timestamp":1466294400000},"content-version":"vor","delay-in-days":323,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.nucmedbio.2015.03.003","type":"journal-article","created":{"date-parts":[[2015,3,26]],"date-time":"2015-03-26T12:41:15Z","timestamp":1427373675000},"page":"695-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP\/PS1 mice but does not increase brain uptake"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4987-7298","authenticated-orcid":false,"given":"Maarten","family":"Rotman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mick M.","family":"Welling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlinde L.","family":"van den Boogaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure Grand","family":"Moursel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"van Buchem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silv\u00e8re M.","family":"van der Maarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"van der Weerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0005","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1096\/fj.13-247478","article-title":"A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation","volume":"28","author":"Yardehnavi","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0010","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.molimm.2008.04.011","article-title":"VHH, bivalent domains and chimeric heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI\u2032","volume":"45","author":"Hmila","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0015","doi-asserted-by":"crossref","first-page":"e00122","DOI":"10.1042\/BSR20140050","article-title":"Wheat germ in vitro translation to produce one of the most toxic sodium channel specific toxins","volume":"34","author":"Gad","year":"2014","journal-title":"Biosci Rep"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0020","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.1128\/JVI.03178-13","article-title":"Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge","volume":"88","author":"Cardoso","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaut.2009.08.012","article-title":"A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetes","volume":"34","author":"Scheuplein","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0030","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.febslet.2010.03.010","article-title":"Structural basis for a PABPN1 aggregation-preventing antibody fragment in OPMD","volume":"584","author":"Impagliazzo","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0035","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.neurobiolaging.2009.11.012","article-title":"Differential recognition of vascular and parenchymal beta amyloid deposition","volume":"32","author":"Rutgers","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2015.02.012","article-title":"Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease","volume":"203C","author":"Rotman","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0045","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1096\/fj.11-201384","article-title":"Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging","volume":"26","author":"Li","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0050","doi-asserted-by":"crossref","first-page":"e38284","DOI":"10.1371\/journal.pone.0038284","article-title":"In vivo detection of amyloid-beta deposits using heavy chain antibody fragments in a transgenic mouse model for alzheimer's disease","volume":"7","author":"Nabuurs","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0055","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.ddtec.2011.11.005","article-title":"Pre-clinical optical imaging and MRI for drug development in Alzheimer's disease","volume":"8","author":"Rotman","year":"2011","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00063030-200923020-00003","article-title":"Strategies to extend plasma half-lives of recombinant antibodies","volume":"23","author":"Kontermann","year":"2009","journal-title":"BioDrugs"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0065","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.copbio.2011.06.012","article-title":"Strategies for extended serum half-life of protein therapeutics","volume":"22","author":"Kontermann","year":"2011","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0070","doi-asserted-by":"crossref","first-page":"19637","DOI":"10.1074\/jbc.M110.117382","article-title":"Enhancing antibody Fc heterodimer formation through electrostatic steering effects: applications to bispecific molecules and monovalent IgG","volume":"285","author":"Gunasekaran","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0075","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1097-2765(01)00230-1","article-title":"Crystal structure at 2.8 A of an FcRn\/heterodimeric Fc complex: mechanism of pH-dependent binding","volume":"7","author":"Martin","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0080","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1038\/nprot.2006.322","article-title":"Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment","volume":"1","author":"Olafsen","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fimmu.2014.00146","article-title":"Interactions of IgG1 CH2 and CH3 domains with FcRn","volume":"5","author":"Ying","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0090","doi-asserted-by":"crossref","first-page":"14606","DOI":"10.1128\/JVI.79.23.14606-14613.2005","article-title":"Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus","volume":"79","author":"Gould","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1389-1723(03)80022-1","article-title":"Production of anti-prion scFv-Fc fusion proteins by recombinant animal cells","volume":"95","author":"Ono","year":"2003","journal-title":"J Biosci Bioeng"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0100","doi-asserted-by":"crossref","first-page":"10864","DOI":"10.1128\/JVI.79.17.10864-10874.2005","article-title":"High-level expression of single-chain Fv-Fc fusion protein in serum and egg white of genetically manipulated chickens by using a retroviral vector","volume":"79","author":"Kamihira","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-1759(00)00290-8","article-title":"Expression of single-chain Fv-Fc fusions in Pichia pastoris","volume":"251","author":"Powers","year":"2001","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0110","doi-asserted-by":"crossref","first-page":"e69495","DOI":"10.1371\/journal.pone.0069495","article-title":"In vivo neutralization of alpha-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody","volume":"8","author":"Richard","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-61779-968-6_19","article-title":"Production of camel-like antibodies in plants","volume":"911","author":"De Buck","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0120","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/pbi.12094","article-title":"Fusion of an Fc chain to a VHH boosts the accumulation levels in Arabidopsis seeds","volume":"11","author":"De Buck","year":"2013","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0125","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.bbrc.2011.04.090","article-title":"Single-domain antibodies that compete with the natural ligand fibroblast growth factor block the internalization of the fibroblast growth factor receptor 1","volume":"408","author":"Veggiani","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2009.08.003","article-title":"Differential tumor-targeting abilities of three single-domain antibody formats","volume":"289","author":"Bell","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0135","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1096\/fj.14-253369","article-title":"A novel platform for engineering blood-brain barrier-crossing bispecific biologics","volume":"28","author":"Farrington","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hyb.2006.037","article-title":"Production of chimeric recombinant single domain antibody-green fluorescent fusion protein in Chinese hamster ovary cells","volume":"26","author":"Bazl","year":"2007","journal-title":"Hybridoma (Larchmt)"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0145","doi-asserted-by":"crossref","first-page":"658954","DOI":"10.1155\/2010\/658954","article-title":"The availability of a recombinant anti-SNAP antibody in VHH format amplifies the application flexibility of SNAP-tagged proteins","volume":"2010","author":"Aliprandi","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuroscience.2011.05.076","article-title":"Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood-brain barrier","volume":"190","author":"Rutgers","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1601-183X.2006.00221.x","article-title":"Impaired spatial learning in the APPSwe+PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease","volume":"6","author":"Reiserer","year":"2007","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0165","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","article-title":"AMIDE: a free software tool for multimodality medical image analysis","volume":"2","author":"Loening","year":"2003","journal-title":"Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0170","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1471-4159.2005.03463.x","article-title":"The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells","volume":"95","author":"Abulrob","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0175","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1096\/fj.01-0343fje","article-title":"Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium","volume":"16","author":"Muruganandam","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/B978-0-12-396962-0.00011-2","article-title":"Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier","volume":"503","author":"Pardridge","year":"2012","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Niewoehner","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0190","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.phrs.2009.02.007","article-title":"Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human","volume":"59","author":"Warren","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0195","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.bbi.2010.05.010","article-title":"Intramuscular delivery of a single chain antibody gene prevents brain Abeta deposition and cognitive impairment in a mouse model of Alzheimer's disease","volume":"24","author":"Wang","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0200","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm1635","article-title":"Clearance of amyloid-beta by circulating lipoprotein receptors","volume":"13","author":"Sagare","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0205","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nri1843","article-title":"Immunology and immunotherapy of Alzheimer's disease","volume":"6","author":"Weiner","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nucmedbio.2015.03.003_bb0210","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1523-1755.2002.00687.x","article-title":"Nephrotoxic nephritis is mediated by Fcgamma receptors on circulating leukocytes and not intrinsic renal cells","volume":"62","author":"Tarzi","year":"2002","journal-title":"Kidney Int"},{"issue":"Suppl.","key":"10.1016\/j.nucmedbio.2015.03.003_bb0215","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.nucmedbio.2014.01.009","article-title":"Biodistribution of a (67)Ga-labeled anti-TNF VHH single-domain antibody containing a bacterial albumin-binding domain (Zag)","volume":"41","author":"Morais","year":"2014","journal-title":"Nucl Med Biol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805115000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805115000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T08:45:56Z","timestamp":1566463556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805115000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0969805115000554"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2015.03.003","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP\/PS1 mice but does not increase brain uptake","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2015.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}